Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Austin Fletcher

Vascular & Interventional Radiology Sioux Falls, SD Medical Doctor

NPI 1275028136 CMS profile 4987886

1210 W 18Th St Ste Ll03, Sioux Falls, SD 57104

Open in the dashboard

General payments

$4,874

35 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Austin Fletcher of Sioux Falls, SD is reported in the CMS Open Payments database as having received $4,874 across 35 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 63rd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $190 5
2024 General $2,141 19
2023 General $2,490 9
2021 General $36 1
2019 General $17 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Austin Fletcher
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Austin Fletcher were reported at $190. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Austin Fletcher Vascular & Interventional Radiology median Middle half National median
2019 $17 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $36 $280 $99–$866 $132
2022 $0 $433 $137–$1,497 $149
2023 $2,490 $506 $152–$2,019 $160
2024 $2,141 $556 $175–$1,930 $164
2025 $190 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $2,459 10 payments
  2. Inari Medical, Inc. $1,469 9 payments
  3. Ethicon US, LLC $287 3 payments
  4. Medtronic, Inc. $222 3 payments
  5. Terumo Medical Corporation $121 2 payments
  6. Penumbra, Inc. $92 1 payment
  7. Balt USA, LLC $78 1 payment
  8. Urogen Pharma, Inc. $47 2 payments
  9. Abbott Laboratories $31 1 payment
  10. Stryker Corporation $29 1 payment
  11. Other $40 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $2,828 6 payments
  2. Food and Beverage $2,046 29 payments
Products named General payments · program years 2019–2025
  1. TheraSphere Y90 Glass Microspheres 10 GBq $2,255 6 payments
  2. FLOWTRIEVER CATHETER, S $1,469 9 payments
  3. CT THROMBECTOMY SYSTEM KIT $1,469 9 payments
  4. Neuwave $287 3 payments
  5. Azur CX Detachable $214 3 payments
  6. OSTEOCOOL RF ABLATION SYSTEM $167 1 payment
  7. Intracept $97 1 payment
  8. Indigo System $92 1 payment
  9. Prestige Coil System $78 1 payment
  10. JELMYTO $47 2 payments
  11. Other $218 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 138 billing codes

Paid by Medicare

$41,022

Medicare's payments for the services billed

Medicare patients

692

Average age 73

Services billed

1,079

358 women, 334 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Ischemic heart disease 46%
Chronic kidney disease 38%
Diabetes 34%
Heart failure 31%
Depression 30%
Atrial fibrillation 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
JELMYTO
  • UROGEN PHARMA, INC. $47
$47 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

35 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record